ADMA Biologics Inc (ADMA)
17.41
-0.31
(-1.75%)
USD |
NASDAQ |
Dec 24, 16:00
ADMA Biologics Profit Margin (Quarterly): 29.96% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Corcept Therapeutics Inc | 25.86% |
| Alnylam Pharmaceuticals Inc | -22.27% |
| Catalyst Pharmaceuticals Inc | 34.10% |
| Sarepta Therapeutics Inc | 7.19% |
| Krystal Biotech Inc | 32.42% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 39.59% |
| Return on Assets | 18.97% |
| Return on Invested Capital | 22.77% |
| Gross Profit Margin (Quarterly) | 49.78% |
| Operating Margin (Quarterly) | 33.08% |
| Return on Net Operating Assets | 24.46% |